CookieStocks
ABT: what changed in its latest quarter. Quarter ended Sep 30, 2026 vs the same quarter a year earlier, from ABBOTT LABORATORIES’s SEC filing.

2026-11-09 · ABT

ABT: what changed in its latest quarter

Quarter ended Sep 30, 2026 vs the same quarter a year earlier, from ABBOTT LABORATORIES’s SEC filing.

The story in plain words

Monday, November 9, 2026. ABT: what changed in its latest quarter. Quarter ended Sep 30, 2026 vs the same quarter a year earlier, from ABBOTT LABORATORIES’s SEC filing.

What the data shows for Abbott Laboratories (ABT): Revenue growth: +14.5% vs the same quarter a year earlier. EPS growth: −43.6% vs the same quarter a year earlier. Gross margin: +1.4 pts vs the same quarter a year earlier. Operating margin: −7.7 pts vs the same quarter a year earlier. Free cash flow: −46.6% vs the same quarter a year earlier.

About the company: Abbott Laboratories trades as ABT and is part of the S&P 500, in the Health Care sector (Health Care Equipment), headquartered in North Chicago, Illinois, founded in 1888.

This is one of CookieStocks’ daily stock stories about the biggest year-over-year changes in S&P 500 companies’ reported results, straight from SEC filings. Stories are found automatically each trading day from market data and SEC filings, and every claim is labelled as observed, calculated or a possible contributor. Statistics only, not investment advice.

Prove it

Every claim on the graphic, labelled: observed (straight from the data), calculated (worked out from it), or possible contributor (lines up in time, not a confirmed cause).

  • OBSERVED
    Revenue growth: +14.5% vs the same quarter a year earlierHow: this year ÷ last year − 1 · Source: SEC EDGAR · Nov 4, 2026, 3:00 PM ET
  • OBSERVED
    EPS growth: −43.6% vs the same quarter a year earlierHow: this year ÷ last year − 1 · Source: SEC EDGAR · Nov 4, 2026, 3:00 PM ET
  • OBSERVED
    Gross margin: +1.4 pts vs the same quarter a year earlierHow: this year’s margin − last year’s margin · Source: SEC EDGAR · Nov 4, 2026, 3:00 PM ET
  • OBSERVED
    Operating margin: −7.7 pts vs the same quarter a year earlierHow: this year’s margin − last year’s margin · Source: SEC EDGAR · Nov 4, 2026, 3:00 PM ET
  • OBSERVED
    Free cash flow: −46.6% vs the same quarter a year earlierHow: this year ÷ last year − 1 · Source: SEC EDGAR · Nov 4, 2026, 3:00 PM ET

Abbott Laboratories (ABT) financials and filings →

More stories

Statistics only, not investment advice. Past moves don’t predict future ones. Data as of Nov 9, 2026, 10:35 AM ET.